spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioTrinity 2019

BIO Trinity 2019

30 April - 1 May 2019
etc.venues 155 Bishopsgate, London EC2M 3YD

BioTrinity 2019 is taking place from the 30thApril – 1st May at etc.venues 155 Bishopsgate in London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering and Investment conference in Europe, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.

BioTrinity 2019 incorporates significant improvements including a move to etc.venues 155 Bishopsgate, a central London location.  This new venue allows us to keep all activity on one floor which will focus the energy and facilitate interaction, thereby maximising visibility for our sponsors, exhibitors, BioLaunchPad® presenters and creating even more opportunities for networking and informal meetings.

The focus of the 2019 conference is to look at 'What’s new' in the industry, and we’ll be providing updates and insight on both technical and financial developments across a wide range of key therapeutics areas – have a look at the Draft Programme.

BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors.

Social Media:

Twitter - @biotrinity & @OBN_UK

LinkedIn - https://www.linkedin.com/company/1016463/

Website - http://www.biotrinity.com/

Contact:
OBN Events
events@obn.org.uk

phone +44 (0)1235 420870
email events@obn.org.uk
web www.biotrinity.com/
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

White Papers

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific.

Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific.
More info >>


News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement